Health
Sanofi’s mRNA COVID-19 vaccine candidate not ready this year, CEO says By Reuters – Investing.com
Sanofi’s mRNA COVID-19 vaccine candidate not ready this year, CEO says
PARIS (Reuters) – A COVID-19 vaccine candidate developed by Sanofi (NASDAQ:SNY) and U.S. group Translate Bio (NASDAQ:TBIO) “will not be ready this year,” the French drugmaker’s chief executive told Le Journal du Dimanche newspaper.
Clinical trials of this vaccine, which will be based on a technology known as mRNA — on which lean approved vaccines of Pfizer/BioNTech and Moderna (NASDAQ:MRNA) –, are expected to start this quarter.
In December last year, Sanofi had said it was targeting “earliest…
-
Business20 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Noosa News17 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business16 hours agoDicker Data rides the AI trend to double digit growth
-
Business20 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy